메뉴 건너뛰기




Volumn 366, Issue 20, 2012, Pages 1859-1869

Warfarin and aspirin in patients with heart failure and sinus rhythm

(535)  Homma, Shunichi a   Thompson, John L P a   Pullicino, Patrick M b   Levin, Bruce a   Freudenberger, Ronald S d   Teerlink, John R e,f   Ammon, Susan E f   Graham, Susan g   Sacco, Ralph L h   Mann, Douglas L i   Mohr, J P a   Massie, Barry M e,f   Labovitz, Arthur J j   Anker, Stefan D k,l   Lok, Dirk J m   Ponikowski, Piotr n   Estol, Conrado J o   Lip, Gregory Y H c   Di Tullio, Marco R a   Sanford, Alexandra R a   more..


Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; WARFARIN;

EID: 84861037910     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1202299     Document Type: Article
Times cited : (466)

References (28)
  • 1
    • 0031911002 scopus 로고    scopus 로고
    • Effect of mitral regurgitation on left ventricular thrombus formation in dilated cardiomyopathy
    • DOI 10.1016/S0002-8703(98)70084-5
    • Kalaria VG, Passannante MR, Shah T, Modi K, Weisse AB. Effect of mitral regurgitation on left ventricular thrombus formation in dilated cardiomyopathy. Am Heart J 1998;135:215-20. (Pubitemid 28139159)
    • (1998) American Heart Journal , vol.135 , Issue.2 I , pp. 215-220
    • Kalaria, V.G.1    Passannante, M.R.2    Shah, T.3    Modi, K.4    Weisse, A.B.5
  • 2
    • 0033117108 scopus 로고    scopus 로고
    • Does heart failure confer a hypercoagulable state? Virchow's triad revisited
    • Lip GYH, Gibbs CR. Does heart failure confer a hypercoagulable state? Virchow's triad revisited. J Am Coll Cardiol 1999;33:1424-6.
    • (1999) J Am Coll Cardiol , vol.33 , pp. 1424-1426
    • Lip, G.Y.H.1    Gibbs, C.R.2
  • 4
    • 33750360340 scopus 로고    scopus 로고
    • Should we use anticoagulation for patients with chronic heart failure?
    • DOI 10.1038/ncpcardio0688, PII NCPCARDIO0688
    • Freudenberger RS, Halperin JL. Should we use anticoagulation for patients with chronic heart failure? Nat Clin Pract Cardiovasc Med 2006;3:580-1. (Pubitemid 44614915)
    • (2006) Nature Clinical Practice Cardiovascular Medicine , vol.3 , Issue.11 , pp. 580-581
    • Freudenberger, R.S.1    Halperin, J.L.2
  • 5
    • 0032572314 scopus 로고    scopus 로고
    • Antithrombotics for leftventricular impairment?
    • Ezekowitz M. Antithrombotics for leftventricular impairment? Lancet 1998;351: 1904.
    • (1998) Lancet , vol.351 , pp. 1904
    • Ezekowitz, M.1
  • 6
    • 33645737200 scopus 로고    scopus 로고
    • Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke - Co-sponsored by the Council on Cardiovascular Radiology and Intervention. The American Academy of Neurology affirms the value of this guideline
    • DOI 10.1161/01.STR.0000199147.30016.74, PII 0000301720060314000024
    • Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation 2006;113(10):e409-e449. (Pubitemid 43739468)
    • (2006) Circulation , vol.113 , Issue.10
    • Sacco, R.L.1    Adams, R.2    Albers, G.3    Alberts, M.J.4    Benavente, O.5    Furie, K.6    Goldstein, L.B.7    Gorelick, P.8    Halperin, J.9    Harbaugh, R.10    Johnston, S.C.11    Katzan, I.12    Kelly-Hayes, M.13    Kenton, E.J.14    Marks, M.15    Schwamm, L.H.16    Tomsick, T.17
  • 7
    • 0001566516 scopus 로고
    • The effects of dicumarol upon the mortality and incidence of thromboembolic complications in congestive heart failure
    • Anderson GM, Hull E. The effects of dicumarol upon the mortality and incidence of thromboembolic complications in congestive heart failure. Am Heart J 1950;39:697-702.
    • (1950) Am Heart J , vol.39 , pp. 697-702
    • Anderson, G.M.1    Hull, E.2
  • 8
    • 0000315462 scopus 로고
    • A study of the beneficial effects of anticoagulant therapy in congestive heart failure
    • Griffith GC, Stragnell R, Levinson DC, Moore FJ, Ware AG. A study of the beneficial effects of anticoagulant therapy in congestive heart failure. Ann Intern Med 1952;37:867-87.
    • (1952) Ann Intern Med , vol.37 , pp. 867-887
    • Griffith, G.C.1    Stragnell, R.2    Levinson, D.C.3    Moore, F.J.4    Ware, A.G.5
  • 9
    • 0001459066 scopus 로고
    • Dicumarol prophylaxis of thromboembolic disease in congestive heart failure
    • Harvey WP, Finch CA. Dicumarol prophylaxis of thromboembolic disease in congestive heart failure. N Engl J Med 1950;242:208-11.
    • (1950) N Engl J Med , vol.242 , pp. 208-211
    • Harvey, W.P.1    Finch, C.A.2
  • 14
  • 16
    • 65249116339 scopus 로고    scopus 로고
    • Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial
    • Massie BM, Collins JF, Ammon SE, et al. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation 2009;119: 1616-24.
    • (2009) Circulation , vol.119 , pp. 1616-1624
    • Massie, B.M.1    Collins, J.F.2    Ammon, S.E.3
  • 17
    • 33144465561 scopus 로고    scopus 로고
    • Warfarin Versus Aspirin in Patients with Reduced Cardiac Ejection Fraction (WARCEF): Rationale, objectives, and design
    • DOI 10.1016/j.cardfail.2005.07.007, PII S1071916405007153
    • Pullicino P, Thompson JL, Barton B, et al. Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design. J Card Fail 2006;12:39-46. (Pubitemid 43267750)
    • (2006) Journal of Cardiac Failure , vol.12 , Issue.1 , pp. 39-46
    • Pullicino, P.1    Thompson, J.L.P.2    Barton, B.3    Levin, B.4    Graham, S.5    Freudenberger, R.S.6
  • 18
    • 0010168781 scopus 로고
    • Test of an algorithm for simulating prothrombin times in a double-blind anticoagulation drug trial
    • abstract
    • Thompson JLP, Fleiss JL, James K, et al. Test of an algorithm for simulating prothrombin times in a double-blind anticoagulation drug trial. Ann Neurol 1994; 36:305-6. abstract.
    • (1994) Ann Neurol , vol.36 , pp. 305-306
    • Thompson, J.L.P.1    Fleiss, J.L.2    James, K.3
  • 20
    • 0035892035 scopus 로고    scopus 로고
    • A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
    • Mohr JP, Thompson JL, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001;345:1444-51.
    • (2001) N Engl J Med , vol.345 , pp. 1444-1451
    • Mohr, J.P.1    Thompson, J.L.2    Lazar, R.M.3
  • 21
    • 0033527355 scopus 로고    scopus 로고
    • Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis
    • Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999;131:492-501. (Pubitemid 29482392)
    • (1999) Annals of Internal Medicine , vol.131 , Issue.7 , pp. 492-501
    • Hart, R.G.1    Benavente, O.2    McBride, R.3    Pearce, L.A.4
  • 22
    • 0027051507 scopus 로고
    • Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure
    • Hall D, Zeitler H, Rudolph W. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol 1992;20:1549-55. (Pubitemid 23007509)
    • (1992) Journal of the American College of Cardiology , vol.20 , Issue.7 , pp. 1549-1555
    • Hall, D.1    Zeitler, H.2    Rudolph, W.3
  • 25
    • 0037072090 scopus 로고    scopus 로고
    • Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): A randomised controlled trial
    • DOI 10.1016/S0140-6736(02)09409-6
    • van Es RF, Jonker JJ, Verheugt FW, Deckers JW, Grobbee DE. Aspirin and Coumadin After Acute Coronary Syndromes (the ASPECT-2 study): a randomized controlled trial. Lancet 2002;360:109-13. (Pubitemid 34786198)
    • (2002) Lancet , vol.360 , Issue.9327 , pp. 109-113
    • Van Es, R.F.1    Jonker, J.J.C.2    Verheugt, F.W.A.3    Deckers, J.W.4    Grobbee, D.E.5
  • 26
    • 70349306707 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation
    • Erratum, N Engl J Med 2010;363:1877
    • Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51. [Erratum, N Engl J Med 2010;363:1877.]
    • (2009) N Engl J Med , vol.361 , pp. 1139-1151
    • Connolly, S.J.1    Ezekowitz, M.D.2    Yusuf, S.3
  • 27
    • 80052592404 scopus 로고    scopus 로고
    • Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
    • Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365:883-91.
    • (2011) N Engl J Med , vol.365 , pp. 883-891
    • Patel, M.R.1    Mahaffey, K.W.2    Garg, J.3
  • 28
    • 80052825103 scopus 로고    scopus 로고
    • Apixaban versus warfarin in patients with atrial fibrillation
    • Granger CB, Alexander JH, McMurray JJV, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981-92.
    • (2011) N Engl J Med , vol.365 , pp. 981-992
    • Granger, C.B.1    Alexander, J.H.2    McMurray, J.J.V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.